A Combined Clinical and Serum Biomarker-Based Approach May Allow Early Differentiation Between Patients With Minor Stroke and Transient Ischemic Attack as Well as Mid-term Prognostication

A Combined Clinical and Serum Biomarker-Based Approach May Allow Early Differentiation Between Patients With Minor Stroke and Transient Ischemic Attack as Well as Mid-term Prognostication

Background: Early differentiation between transient ischemic attack (TIA) and minor ischemic stroke (MIS) impacts on the patient's individual diagnostic work-up and treatment. Furthermore, estimations regarding persisting impairments after MIS are essential to guide rehabilitation programs. Thi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Johann Otto Pelz, Katharina Kubitz, Manja Kamprad-Lachmann, Kristian Harms, Martin Federbusch, Carsten Hobohm, Dominik Michalski
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
biomarker panel
minor ischemic stroke
transient ischemic attack
prognostication
functional impairment
Neurology. Diseases of the nervous system
RC346-429
Acceso en línea:https://doaj.org/article/69a2cf70457e454fb544031d12793291
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/69a2cf70457e454fb544031d12793291

Ejemplares similares